Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Colorcon
McKesson
Dow
Merck
Baxter
UBS
Express Scripts
Johnson and Johnson

Generated: November 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075858

« Back to Dashboard

NDA 075858 describes HALOPERIDOL, which is a drug marketed by Alpharma, Lannett Co Inc, Morton Grove, Pharm Assoc, SCS, Teva, Teva Pharms, Abraxis Pharm, Akorn, Baxter Hlthcare Corp, Fosun Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Marsam Pharms Llc, Mylan Labs Ltd, Sagent Pharms, Smith And Nephew, Solopak, Teva Pharms Usa, Watson Labs, West-ward Pharms Int, Anda Repository, Cycle Pharms Ltd, Duramed Pharms Barr, Lederle, Mylan, Par Pharm, Purepac Pharm, Quantum Pharmics, Royce Labs, Sandoz, Vintage, Zydus Pharms Usa, Hospira, Sandoz Inc, Somerset Theraps Llc, and Actavis Mid Atlantic, and is included in one hundred and seven NDAs. It is available from thirty-six suppliers. Additional details are available on the HALOPERIDOL profile page.

The generic ingredient in HALOPERIDOL is haloperidol decanoate. There are twenty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the haloperidol decanoate profile page.
Summary for 075858
Tradename:HALOPERIDOL
Applicant:West-ward Pharms Int
Ingredient:haloperidol lactate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 075858
Suppliers and Packaging for NDA: 075858
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HALOPERIDOL haloperidol lactate INJECTABLE;INJECTION 075858 ANDA West-Ward Pharmaceuticals Corp 0143-9319 0143-9319-25 25 VIAL in 1 BOX (0143-9319-25) > 1 mL in 1 VIAL
HALOPERIDOL haloperidol lactate INJECTABLE;INJECTION 075858 ANDA West-Ward Pharmaceuticals Corp 0143-9501 0143-9501-25 25 VIAL in 1 BOX (0143-9501-25) > 1 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 5MG BASE/ML
Approval Date:Jun 18, 2001TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Accenture
Chubb
Citi
Deloitte
Baxter
Dow
Harvard Business School
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.